Skip to content

Xilaplus AF comprimidos

by Noventure S.L.U.

Ref 1291414Model Xilaplus AF tablets

Active European Union

CE MDR

Valid until

14 Nov 2029

CE MDR certificate

FDA recalls

Not applicable

No FDA record for this device

Documents

2 certificates

Certifier KIWA CERMET ITALIA S.P.A.

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source EUDAMED, synced 23 Oct 2026. What this means

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR NumberMDR 00064-A Date27 Mar 2025IssuedStatusActive expires 14 Nov 2029

Certificates

2 certificates · EUDAMED

EUDAMED certificates (2)
  • MDR 00064-A Active

    Quality management system EU MDR

    Issued
    27 Mar 2025
    Expires
    14 Nov 2029
  • MDR 00064-B Active

    Technical documentation EU MDR

    Issued
    27 Mar 2025
    Expires
    14 Nov 2029

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Active

Specification

EUDAMED

Device Name
Xilaplus AF tablets
Model / Reference
Xilaplus AF tablets, 1291414
Primary DI / UDI-DI
08436593830052
Basic UDI-DI
843659383XIA653NF
Direct Marketing DI
08436593830052
EMDN Code
G0402 Orally administered devices for appetite control and reduction of intestinal absorption
Device Class
Class III
EU market of registration
Spain

Manufacturer details

EUDAMED SRN
ES-MF-000000797

Other devices from Noventure S.L.U.

See all devices from Noventure S.L.U. →

Properties

Other properties (13)

  • Sterile: No
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No